Fabien Boulineau, PhD

Director, Analytical Development

Fabien Boulineau, PhD, is Director of Analytical Development at Tisento Therapeutics. He brings more than 18 years of experience in analytical development of clinical products from first-in-human trials to commercialization. Previously, Fabien led analytical development activities at Cyclerion Therapeutics and prior to that at Bristol-Myers Squib/Celgene, Merck/Schering-Plough, and AstraZeneca. He has deep expertise in active pharmaceutical and solid oral dosage forms testing, stability, and shelf-life projection. He strongly believes that the manufacturing and delivery of a pharmaceutical product comes from the close collaboration of process, formulation, analytical chemists, and clinical supply coordinators. Outside of work, Fabien enjoys hiking, cooking, and learning home improvement. 

Proudest professional accomplishment: NDA filing of fedratinib at Celgene

Favorite quote: “The only thing we have to fear is fear itself.”
― Franklin D. Roosevelt